These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 19466922

  • 1. Comparison of costs and utilization among buprenorphine and methadone patients.
    Barnett PG.
    Addiction; 2009 Jun; 104(6):982-92. PubMed ID: 19466922
    [Abstract] [Full Text] [Related]

  • 2. Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment.
    Bell J, Trinh L, Butler B, Randall D, Rubin G.
    Addiction; 2009 Jul; 104(7):1193-200. PubMed ID: 19563562
    [Abstract] [Full Text] [Related]

  • 3. The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?
    Sullivan LE, Chawarski M, O'Connor PG, Schottenfeld RS, Fiellin DA.
    Drug Alcohol Depend; 2005 Jul; 79(1):113-6. PubMed ID: 15943950
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Exposure to opioid maintenance treatment reduces long-term mortality.
    Gibson A, Degenhardt L, Mattick RP, Ali R, White J, O'Brien S.
    Addiction; 2008 Mar; 103(3):462-8. PubMed ID: 18190664
    [Abstract] [Full Text] [Related]

  • 7. Treatment retention in adolescent patients treated with methadone or buprenorphine for opioid dependence: a file review.
    Bell J, Mutch C.
    Drug Alcohol Rev; 2006 Mar; 25(2):167-71. PubMed ID: 16627307
    [Abstract] [Full Text] [Related]

  • 8. The impact of buprenorphine on treatment of opioid dependence in a Medicaid population: recent service utilization trends in the use of buprenorphine and methadone.
    Stein BD, Gordon AJ, Sorbero M, Dick AW, Schuster J, Farmer C.
    Drug Alcohol Depend; 2012 Jun 01; 123(1-3):72-8. PubMed ID: 22093488
    [Abstract] [Full Text] [Related]

  • 9. Cost and utilization outcomes of opioid-dependence treatments.
    Baser O, Chalk M, Fiellin DA, Gastfriend DR.
    Am J Manag Care; 2011 Jun 01; 17 Suppl 8():S235-48. PubMed ID: 21761950
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.
    Anchersen K, Clausen T, Gossop M, Hansteen V, Waal H.
    Addiction; 2009 Jun 01; 104(6):993-9. PubMed ID: 19392907
    [Abstract] [Full Text] [Related]

  • 13. Implementation of buprenorphine in the Veterans Health Administration: results of the first 3 years.
    Gordon AJ, Trafton JA, Saxon AJ, Gifford AL, Goodman F, Calabrese VS, McNicholas L, Liberto J, Buprenorphine Work Group of the Substance Use Disorders Quality Enhancement Research Initiative.
    Drug Alcohol Depend; 2007 Oct 08; 90(2-3):292-6. PubMed ID: 17493771
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Linking opioid-dependent hospital patients to drug treatment: Health care use and costs 6 months after randomization.
    Barnett PG, Masson CL, Sorensen JL, Wong W, Hall S.
    Addiction; 2006 Dec 08; 101(12):1797-804. PubMed ID: 17156179
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The impact of community pharmacy dispensing fees on the introduction of buprenorphine - naloxone in Australia.
    Winstock AR, Lea T, Ritter A.
    Drug Alcohol Rev; 2007 Jul 08; 26(4):411-6. PubMed ID: 17564877
    [Abstract] [Full Text] [Related]

  • 18. [Buprenorphine or methadone for detoxification of young opioid addicts?].
    Ebner R, Schreiber W, Zierer C.
    Psychiatr Prax; 2004 Nov 08; 31 Suppl 1():S108-10. PubMed ID: 15570521
    [Abstract] [Full Text] [Related]

  • 19. Maintenance therapy and 3-year outcome of opioid-dependent prisoners: a prospective study in France (2003-06).
    Marzo JN, Rotily M, Meroueh F, Varastet M, Hunault C, Obradovic I, Zin A.
    Addiction; 2009 Jul 08; 104(7):1233-40. PubMed ID: 19426291
    [Abstract] [Full Text] [Related]

  • 20. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
    Ridge G, Gossop M, Lintzeris N, Witton J, Strang J.
    J Subst Abuse Treat; 2009 Jul 08; 37(1):95-100. PubMed ID: 19004598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.